The largest database of trusted experimental protocols

Cryostor cell cryopreservation medium

Manufactured by Merck Group
Sourced in United States

CryoStor is a cell cryopreservation medium developed by Merck Group. It is a sterile, ready-to-use solution designed to preserve the viability and functionality of cells during cryogenic storage and transportation.

Automatically generated - may contain errors

4 protocols using cryostor cell cryopreservation medium

1

Isolation and Cryopreservation of Human PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral venous blood was collected in K2-EDTA blood tubes (BD Vacutainer). For scTCR-seq, blood was processed within 10 minutes after withdrawal (cohort 2). For both cohort 1 and cohort 2, blood was diluted 1:2 in PBS containing 2% FCS. A density gradient was created using SepMate PBMC isolation tubes (STEMCELL Technologies) containing Ficoll-Paque Premium (GE Healthcare). Cells were centrifuged at 1,200g for 10 minutes at room temperature. The intermediate layer containing PBMCs was isolated and washed twice with PBS + 2% FCS (250g, 10 minutes, room temperature). Cells were taken up in PBS + 1% BSA until further processing. For cohort 3, whole blood samples were lysed twice with ACK lysis buffer in PBS (1:10) for 10 minutes at room temperature and washed with PBS (300g, 5 minutes). Cells were taken up in RPMI + 1% FCS and cryostored in CryoStor cell cryopreservation medium (Sigma-Aldrich) until further use.
+ Open protocol
+ Expand
2

Isolation of Human Carotid Plaque Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human carotid plaques were collected during CEA; the culprit segment (5 mm) was used for histology and embedded in paraffin as described elsewhere48 (link). In brief, culprit segments were fixed in 4% formaldehyde and decalcified in 10% EDTA, pH 7.5. Afterwards, culprit segments were embedded in paraffin. Time between surgical removal and plaque processing did not exceed 10 minutes. The inclusion of a small medial layer in the dissected tissue could not be excluded during the surgical procedure. The remainder of the plaque was washed in RPMI and minced into small pieces with a razor blade. The tissue was then digested in RPMI 1640 containing 2.5 mg ml−1 of collagenase IV (Thermo Fisher Scientific), 0.25 mg ml−1 of DNAse I (Sigma-Aldrich) and 2.5 mg ml−1 of Human Albumin Fraction V (MP Biomedicals) at 37 °C for 30 minutes. In cohort 2, 1 µM flavopiridol (Selleck Chemicals) was added to the digestion mixture. Subsequently, the plaque cell suspension was filtered through a 70-µm cell strainer and washed with RPMI 1640. Cells were kept in RPMI 1640 with 1% FCS until subsequent staining for flow cytometry (cohort 1), feature barcoding and FACS (cohort 2) or cryostored in CryoStor cell cryopreservation medium (Sigma-Aldrich) until further use.
+ Open protocol
+ Expand
3

Optimized Human Endarterectomy Single-Cell Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endarterectomy samples from cohort 1 and cohort 2 were digested into a single-cell suspension following the same protocol. 28 (link) In brief, a section (1-5 mm) of the culprit segment of the lesion was stored at -80 °C for immunopeptidomics. The remainder of the lesion was digested into a single-cell suspension by cutting the tissue into pieces of ≈1 mm 2 , followed by digestion with 2.5 mg/mL collagenase IV (Thermo Fisher Scientific), 0.25 mg/mL DNAse I (Sigma), 2.5 mg/mL human albumin fraction V (MP Biomedicals) in RPMI 1640 for 30 minutes at 37 °C. After digestion, plaque tissue was mashed over a 70-µm strainer to create a single-cell suspension and washed in RMPI 1640. Cells were cryostored in Cryostor cell cryopreservation medium (Sigma-Aldrich) at -80 °C until further use.
+ Open protocol
+ Expand
4

Cryopreservation of Diagnostic PCD Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Between March 2018 and August 2020 UHS has cryopreserved surplus diagnostic cells from 181 PCD clinic patient samples and 30 healthy donor samples. Surplus cells from passage 1 were frozen 1 million per cryovial in 1 mL CryoStor® cell cryopreservation medium (Sigma, St. Louis, MO, USA, #C2874). Cells were initially frozen at −80 °C (graduated freezing −1 °C/minute in a Mr. FrostyTM container Thermo Fisher Scientific, Waltham, MA, USA, #5100–0001), then transferred to liquid nitrogen for longer-term storage. After thawing, washed cells were seeded for research in a smaller Transwell® insert format in 24-well plates. Briefly, 50,000 cells per collagen-coated 6.5 mm Transwell® with 0.4 µm pore polyester membrane insert (Corning Life Sciences, Corning, NY, USA, #3470) in 100 µL PneumaCult Ex plus medium supplemented (apical side) and 350 µL of the same medium on the basolateral side. Cultures were taken to ALI after 1–2 days replacing only the basolateral medium with 350 µL PneumaCult ALI medium supplemented and maintained as detailed above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!